Cited by 46Alzheimer's disease research and treatmentsDNA Repair MechanismsDementia and Cognitive Impairment Research

Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease

Open access
Lillenes, Meryl S., Rabano, Alberto, Støen, Mari, Riaz, Tahira, Misaghian, Dorna, Møllersen, Linda, Esbensen, Ying, Günther, Clara-Cecilie +4 more·2016·Molecular Brain

Abstract

BACKGROUND: Alzheimer's disease (AD) is a progressive, multifactorial neurodegenerative disorder that is the main cause of dementia globally. AD is associated with increased oxidative stress, resulting from imbalance in production and clearance of reactive oxygen species (ROS). ROS can damage DNA and other macromolecules, leading to genome instability and disrupted cellular functions. Base excision repair (BER) plays a major role in repairing oxidative DNA lesions. Here, we compared the expression of BER components APE1, OGG1, PARP1 and Polβ in blood and postmortem brain tissue from patients with AD, mild cognitive impairment (MCI) and healthy controls (HC). RESULTS: BER mRNA levels were correlated to clinical signs and cerebrospinal fluid biomarkers for AD. Notably, the expression of BER genes was higher in brain tissue than in blood samples. Polβ mRNA and protein levels were significantly higher in the cerebellum than in the other brain regions, more so in AD patients than in HC. Blood mRNA levels of OGG1 was low and PARP1 high in MCI and AD. CONCLUSIONS: These findings reflect the oxidative stress-generating energy-consumption in the brain and the importance of BER in repairing these damage events. The data suggest that alteration in BER gene expression is an event preceding AD. The results link DNA repair in brain and blood to the etiology of AD at the molecular level and can potentially serve in establishing novel biomarkers, particularly in the AD prodromal phase.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13041-016-0237-z

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lillenes, M. S., Rabano, A., Støen, M., Riaz, T., Misaghian, D., Møllersen, L., Esbensen, Y., Günther, C.-C., Selnes, P., Stenset, V. T. V., Fladby, T., & Tønjum, T.
Affiliations
  • Oslo University Hospital (NO)
  • University of Oslo (NO)
  • Norwegian Computing Center (NO)
Corresponding author
Tønjum, Tone
Venue
Molecular Brain
Published
2016-05-28
Volume
9
Issue
1
Pages
61-61
ISSN
1756-6606 (ISSN-L)
OpenAlex
W2406870746
Cited by
46
References
71
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 3 · 2019: 9 · 2018: 2 · 2017: 5
FWCI
4.29
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Brain (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
  • Norges Forskningsråd (191459, 220901)
  • Helse Sør-Øst RHF (2014050, 2014020)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, mild cognitive impairment, DNA base excision repair, oxidative stress, reactive oxygen species, APE1, OGG1, PARP1, DNA polymerase beta, cerebellum, blood biomarkers, cerebrospinal fluid biomarkers, genomic instability, DNA repair gene expression, prodromal Alzheimer's disease
MeSH terms
Poly (ADP-Ribose) Polymerase-1, Aged, Aged, 80 and over, Alzheimer Disease, Brain, DNA Repair, Female, Gene Expression Regulation, Humans, Male, Middle Aged, RNA, Messenger, Biomarkers, Case-Control Studies, Sequence Analysis, RNA, DNA Polymerase beta, DNA-(Apurinic or Apyrimidinic Site) Lyase, DNA Glycosylases, High-Throughput Nucleotide Sequencing, Real-Time Polymerase Chain Reaction, Prodromal Symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review